最近の主な論文 [宮田 学先生]

  1. Miyata M, Ooto S, Muraoka Y. Punctate inner choroidopathy immediately after COVID-19 infection: a case report. BMC Ophthalmol 2022;22(1):297.
  2. Kawai K, Miyata M, Ooto S, et al. Macular atrophy at 5 years after photodynamic therapy for polypoidal choroidal vasculopathy. Eye 2022. doi: 10.1038/s41433-022-02067-6.
  3. Yasuhara S, Miyata M, Ooto S, et al. Predictors of retinal pigment epithelium tear development after treatment for neovascular age-related macular degeneration using swept source optical coherence tomography angiography. Retina 2022;42(6):1020-1027.
  4. Ura S, Miyata M, Ooto S, et al. Contrast-to-noise ratio is a useful predictor of early displacement of large submacular hemorrhage by intravitreal SF6 gas injection. Retina 2022;42(4):661-668.
  5. Shimizu Y, Miyata M, Ooto S, et al. Pachychoroid-phenotype effects on 5-year visual outcomes of anti-VEGF monotherapy in polypoidal choroidal vasculopathy. Acta Ophthalmol 2022;100(4):e943-e949.
  6. Yoshimura A, Miyata M, Muraoka Y, Kawai K, Tsujikawa A. Unilateral transient high myopization after pediatric strabismus surgery: Observation by anterior segment optical coherence tomography. Am J Ophthalmol Case Rep 2022;25(3):101421.
  7. Nakao S, Miyata M, Hirai M, Mizoguchi S, Ohashi H, Nishiwaki H. Rescue of exotropia subsequent to pulled-in-two syndrome of the medial rectus muscle occurring during surgery for high myopic strabismus fixus: A case report. Medicine (Baltimore) 2022;101(52):e31864.
  8. Yagi M, Miyake M, Mori Y, et al. Natural Course of Pachychoroid Pigment Epitheliopathy. Ophthalmol Sci 2022;2(4):100201.
  9. Omoto T, Asaoka R, Akagi T, et al. The number of examinations required for the accurate prediction of the progression of the central 10-degree visual field test in glaucoma. Sci Rep 2022;12(1):18843.
  10. Aisu N, Miyake M, Hosoda Y, et al. Effectiveness of reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy: A propensity score analysis. Ophthalmol Sci 2022;2(2):100152.
  11. Tagawa M, Ooto S, Yamashiro K, et al. Choriocapillaris flow deficit in a pachychoroid spectrum disease using en face optical coherence tomography angiography averaging. PLoS One 2022;17(9):e0271747.
  12. Sakaguchi S, Muraoka Y, Nishigori N, et al. Detection and characteristics of unruptured retinal arterial macroaneurysms. Retina 2022;42(10):1909-1914.
  13. Sakaguchi S, Muraoka Y, Kadomoto S, et al. Three-dimensional locations of ruptured retinal arterial macroaneurysms and their associations with the visual prognosis. Sci Rep 2022;12(1):503.
  14. Mori Y, Miyake M, Hosoda Y, et al. Genome-wide survival analysis for macular neovascularization development in central serous chorioretinopathy revealed shared genetic susceptibility with polypoidal choroidal vasculopathy. Ophthalmology 2022;129(9):1034-1042.
  15. Ideyama M, Muraoka Y, Kawai K, et al. Pigmentary lesions in eyes with rhegmatogenous retinal detachment with flap tears: a retrospective observational study. Sci Rep 2022;12(1):12470.
  16. Ishikura M, Muraoka Y, Nishigori N, et al. Widefield Choroidal Thickness of Eyes with Central Serous Chorioretinopathy Examined by Swept-Source OCT. Ophthalmol Retina 2022;6(10):949-956.
  17. Yoshida M, Oishi A, Miyake M, et al. Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy. Photodiagnosis Photodyn Ther 2022;38(102745):2.
  18. Asaoka R, Miyata M, Oishi A, et al. Relationship between visual acuity and visual field and its reproducibility in patients with retinitis pigmentosa. Eye 2022. doi: 10.1038/s41433-022-02043-0.
  19. Otsuka Y, Oishi A, Miyata M, et al. Evaluation of outer nuclear layer overshadowed by retinal vessels in retinitis pigmentosa. Eye (Lond) 2022;36(5):1042-1049.
  20. Miyata M, Ooto S, Yamashiro K, et al. Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration. Int J Retina Vitreous 2021;7(1):77.
  21. Miyata M, Ooto S, Hata M, Takahashi A, Tsujikawa A. Efficacy of combined anti-VEGF and photodynamic therapy for bilateral diffuse uveal melanocytic proliferation: Case series. Medicine (Baltimore) 2021;100(42):e27578.
  22. Miyata M, Ooto S, Uji A, Tsujikawa A. Retinal artery tortuosity in Marfan's syndrome. QJM 2021;114(8):601-602.
  23. Doi A, Miyata M, Ooto S, et al. Long-term visual outcome in inferior posterior staphyloma and efficacy of treatment for complicated choroidal neovascularization. Am J Ophthalmol 2021;229(152-159.
  24. Asaoka R, Oishi A, Fujino Y, et al. Association between the number of visual fields and the accuracy of future prediction in eyes with retinitis pigmentosa. BMJ Open Ophthalmol 2021;6(1):e000900.
  25. Kawai K, Uji A, Miyazawa T, et al. Prevention of image quality degradation in wider field optical coherence tomography angiography images via image averaging. Transl Vis Sci Technol 2021;10(13):16.
  26. Asano S, Oishi A, Asaoka R, et al. Detecting progression of retinitis pigmentosa using the binomial pointwise linear regression method. Transl Vis Sci Technol 2021;10(13):15.
  27. Hasegawa T, Oishi A, Ikeda HO, et al. Detection sensitivity of retinitis pigmentosa progression using static perimetry and optical coherence tomography. Transl Vis Sci Technol 2021;10(8):31.
  28. Omoto T, Oishi A, Asaoka R, et al. Development and validation of a visual field cluster in retinitis pigmentosa. Sci Rep 2021;11(1):9671.
  29. Nakahara M, Oishi A, Miyata M, et al. Clinical characteristics, differential diagnosis and genetic analysis of concentric retinitis pigmentosa. Life 2021;11(3).
  30. Murakami Y, Koyanagi Y, Fukushima M, et al. Genotype and long-term clinical course of Bietti crystalline dystrophy in Korean and Japanese patients. Ophthalmol Retina 2021;5(12):1269-1279.
  31. Kogo T, Muraoka Y, Uji A, et al. Angiographic risk factors for recurrence of macular edema associated with branch retinal vein occlusion. Retina 2021;41(6):1219-1226.
  32. Elfandi S, Ooto S, Miyata M, et al. Effects of intravitreous aflibercept injection in pachychoroid neovasculopathy: Comparison with typical neovascular age-related macular degeneration. Clin Ophthalmol 2021;15(1539-1549.
  33. Takahashi A, Hosoda Y, Miyake M, et al. Clinical and genetic characteristics of pachydrusen in eyes with central serous chorioretinopathy and general Japanese individuals. Ophthalmol Retina 2021;5(9):910-917.
  34. Kawai K, Uji A, Murakami T, et al. Image evaluation of artificial intelligence supported optical coherence tomography angiography imaging using OCT-HS100 device in diabetic retinopathy. Retina 2021;41(8):1730-1738.
  35. Sawai Y, Miyata M, Uji A, et al. Usefulness of denoising process to depict myopic choroidal neovascularisation using a single optical coherence tomography angiography image. Sci Rep 2020;10(1):6172.
  36. Hosoda Y, Miyake M, Yamashiro K, et al. Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration. Sci Rep 2020;10(1):18423.
  37. Yamamoto A, Miyata M, Suda K. Conjunctival and episcleral blood flow restoration after strabismus surgery on swept-source optical coherence tomography angiography. JAMA Ophthalmol 2019;137(12):e190043.
  38. Uji A, Sadda SR, Muraoka Y, et al. Effect of image averaging on optical coherence tomography angiography data in eyes with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2020;258(8):1639-1648.
  39. Tagawa M, Ooto S, Yamashiro K, et al. Characteristics of pachychoroid neovasculopathy. Sci Rep 2020;10(1):16248.
  40. Shibata K, Hamasaki I, Toshima S, et al. Formulas to estimate appropriate surgical amounts of unilateral recession-resection in intermittent exotropia with distance-near disparity. Acta Med Okayama 2020;74(3):229-236.
  41. Otsuka Y, Oishi A, Miyata M, et al. Wavelength of light and photophobia in inherited retinal dystrophy. Sci Rep 2020;10(1):14798.
  42. Oishi A, Noda K, Birtel J, et al. Effect of smoking on macular function and retinal structure in retinitis pigmentosa. Brain Commun 2020;2(2):fcaa117.
  43. Numa S, Oishi A, Higasa K, et al. EYS is a major gene involved in retinitis pigmentosa in Japan: genetic landscapes revealed by stepwise genetic screening. Sci Rep 2020;10(1):020-77558.
  44. Morisawa S, Hamasaki I, Shibata K, et al. Risk factors for excessive postoperative exo-drift after unilateral lateral rectus muscle recession and medial rectus muscle resection for intermittent exotropia. BMC Ophthalmol 2020;20(1):216.
  45. Morino MU, Akagi T, Miyata M, Tsujikawa A. Removal of a baerveldt glaucoma implant and fibrous adhesion for refractory mechanical strabismus. Case Rep Ophthalmol 2020;11(2):249-255.
  46. Kogo T, Muraoka Y, Iida Y, et al. Angiographic risk features of branch retinal vein occlusion onset as determined by optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2020;61(2):8.
  47. Hashimoto H, Hata M, Kashii S, et al. Analysis of retinal nerve fibre thickening in progressive and non-progressive non-arteritic anterior ischaemic optic neuropathy using optical coherence tomography. Neuroophthalmology 2020;44(5):307-314.
  48. Terada N, Miyata M, Muraoka Y, et al. Abnormal outer choroidal vasculature in amblyopia. J Ophthalmol 2019;2019(2097087.
  49. Miyata M, Suda K, Uji A, et al. One-year outcome predictors of strabismus surgery from anterior segment optical coherence tomography with multiple B-scan averaging. Sci Rep 2019;9(1):2523.
  50. Miyata M, Ooto S, Yamashiro K, et al. Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy. Br J Ophthalmol 2019;103(5):617-622.
  51. Miyata M, Oishi A, Hasegawa T, et al. Concentric choriocapillaris flow deficits in retinitis pigmentosa detected using wide-angle swept-source optical coherence tomography angiography. Invest Ophthalmol Vis Sci 2019;60(4):1044-1049.
  52. Oishi A, Miyata M, Numa S, Otsuka Y, Oishi M, Tsujikawa A. Wide-field fundus autofluorescence imaging in patients with hereditary retinal degeneration: a literature review. Int J Retina Vitreous 2019;5(Suppl 1):23.
  53. Nishikawa K, Oishi A, Hata M, et al. Four-year outcome of aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Sci Rep 2019;9(1):3620.
  54. Kogo T, Muraoka Y, Ooto S, et al. Fixation status after resolution of macular edema associated with branch retinal vein occlusion. Retina 2019;39(10):1896-1905.
  55. Kadomoto S, Uji A, Muraoka Y, Akagi T, Miyata M, Tsujikawa A. A novel strategy for quantification of panoramic en face optical coherence tomography angiography scan field. Graefes Arch Clin Exp Ophthalmol 2019;257(6):1199-1206.
  56. Hosoda Y, Yamashiro K, Miyake M, et al. Predictive genes for the prognosis of central serous chorioretinopathy. Ophthalmol Retina 2019;3(11):985-992.
  57. Hosoda Y, Miyake M, Schellevis RL, et al. Genome-wide association analyses identify two susceptibility loci for pachychoroid disease central serous chorioretinopathy. Commun Biol 2019;2(468.
  58. Hata M, Tagawa M, Oishi A, et al. Efficacy of photodynamic therapy for polypoidal choroidal vasculopathy associated with and without pachychoroid phenotypes. Ophthalmol Retina 2019;3(12):1016-1025.
  59. Miyata M, Yoshikawa M, Ohtsuki H, et al. Age-related change and sex difference over 60s in disc-fovea angle in Japanese population: the Nagahama Study. Acta Ophthalmol 2018;96(7):e840-e845.
  60. Miyata M, Shibata K, Hamasaki I, et al. Predictive factors for corrective effect of inferior rectus recession for congenital superior oblique palsy. Graefes Arch Clin Exp Ophthalmol 2018;256(2):403-409.
  61. Miyata M, Oishi A, Tsujikawa A. Swept-source optical coherence tomography angiography of microaneurysms in myopic retinoschisis. JAMA Ophthalmol 2018;136(8):e181637.
  62. Miyata M, Oishi A, Oishi M, Hasegawa T, Ikeda HO, Tsujikawa A. Long-term efficacy and safety of anti-VEGF therapy in retinitis pigmentosa: a case report. BMC Ophthalmol 2018;18(1):248.
  63. Miyata M, Oishi A, Ogino K, et al. Relationship between ocular deviation and visual runction in retinitis pigmentosa. Sci Rep 2018;8(1):14880.
  64. Miyata M, Oishi A, Hasegawa T, et al. Choriocapillaris flow deficit in Bietti crystalline dystrophy detected using optical coherence tomography angiography. Br J Ophthalmol 2018;102(9):1208-1212.
  65. Hosoda Y, Miyata M, Uji A, et al. Novel predictors of visual outcome in anti-VEGF therapy for myopic choroidal neovascularization derived using OCT angiography. Ophthalmol Retina 2018;2(11):1118-1124.
  66. Wakazono T, Yamashiro K, Miyake M, et al. Time-course change in eye shape and development of dtaphyloma in highly myopic eyes. Invest Ophthalmol Vis Sci 2018;59(13):5455-5461.
  67. Takahashi A, Ooto S, Yamashiro K, et al. Pachychoroid geographic atrophy: Clinical and genetic characteristics. Ophthalmol Retina 2018;2(4):295-305.
  68. Oishi A, Oishi M, Miyata M, et al. Multimodal imaging for differential diagnosis of Bietti crystalline dystrophy. Ophthalmol Retina 2018;2(10):1071-1077.
  69. Kuroda Y, Yamashiro K, Ooto S, et al. Macular atrophy and macular morphology in aflibercept-treated neovascular age-related macular degeneration. Retina 2018;38(9):1743-1750.
  70. Hamasaki I, Shibata K, Shimizu T, et al. Differences in the stability and amount of postoperative exodrift with age after unilateral lateral rectus muscle recession and medial rectus muscle resection of intermittent exotropia. Acta Med Okayama 2018;72(5):487-492.
  71. Akagi T, Uji A, Huang AS, et al. Conjunctival and intrascleral vasculatures assessed using anterior segment optical coherence tomography angiography in normal eyes. Am J Ophthalmol 2018;196(1-9.
  72. Sugahara M, Miyata M, Ishihara K, et al. Optical coherence tomography angiography to estimate retinal blood flow in eyes with retinitis pigmentosa. Sci Rep 2017;7(4):46396.
  73. Miyata M, Hata M, Ooto S, et al. Choroidal and retinal atrophy of Bietti crystalline dystrophy patients with CYP4V2 mutations compared to retinitis pigmentosa patients with EYS mutations. Retina 2017;37(6):1193-1202.
  74. Hirashima T, Miyata M, Ishihara K, et al. Choroidal vasculature in Bietti crystalline dystrophy with CYP4V2 mutations and in retinitis pigmentosa with EYS mutations. Invest Ophthalmol Vis Sci 2017;58(10):3871-3878.
  75. Yoshikawa M, Yamashiro K, Nakanishi H, et al. Association of SIX1/SIX6 locus polymorphisms with regional circumpapillary retinal nerve fibre layer thickness: The Nagahama study. Sci Rep 2017;7(1):4393.
  76. Kawashima Y, Hata M, Oishi A, et al. Association of vascular versus avascular subretinal hyperreflective material with aflibercept response in age-related macular degeneration. Am J Ophthalmol 2017;181(9):61-70.
  77. Hata M, Yamashiro K, Ooto S, et al. Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2017;58(1):292-298.
  78. Hata M, Yamashiro K, Oishi A, et al. Retinal pigment epithelial atrophy after anti-Vascular endothelial growth factor injections for retinal angiomatous proliferation. Retina 2017;37(11):2069-2077.
  79. Hata M, Oishi A, Muraoka Y, et al. Structural and functional analyses in nonarteritic anterior ischemic optic neuropathy: Optical coherence tomography angiography study. J Neuroophthalmol 2017;37(2):140-148.
  80. Miyata M, Ooto S, Ogino K, et al. Evaluation of photoreceptors in Bietti crystalline dystrophy with CYP4V2 mutations using adaptive optics scanning laser ophthalmoscopy. Am J Ophthalmol 2016;161(1):196-205.
  81. Miyata M, Ooto S, Hata M, et al. Detection of myopic choroidal neovascularization using optical coherence tomography angiography. Am J Ophthalmol 2016;165(5):108-114.
  82. Miyata M, Ogino K, Gotoh N, et al. Inner segment ellipsoid band length is a prognostic factor in retinitis pigmentosa associated with EYS mutations: 5-year observation of retinal structure. Eye (Lond) 2016;30(12):1588-1592.
  83. Miyata M, Nakahara R, Hamasaki I, Hasebe S, Furuse T, Ohtsuki H. Quantitative analysis of the effects of a Bangerter filter on gross stereopsis in experimental models of reduced visual acuity. Acta Med Okayama 2016;70(5):339-344.
  84. Ogino K, Oishi A, Oishi M, et al. Efficacy of column scatter plots for presenting retinitis pigmentosa phenotypes in a Japanese cohort. Transl Vis Sci Technol 2016;5(2):4.
  85. Nakano E, Hata M, Oishi A, et al. Quantitative comparison of disc rim color in optic nerve atrophy of compressive optic neuropathy and glaucomatous optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2016;254(8):1609-1616.
  86. Miyata M, Shira Y, Kono R, Hamasaki I, Hasebe S, Ohtsuki H. Effects of vertical muscle surgery on differences in the orientation of Listing's plane in patients with superior oblique palsy. Graefes Arch Clin Exp Ophthalmol 2013;251(10):2437-2443.
  87. Hasebe S, Ohtsuki H, Nonaka T, et al. Effect of progressive addition lenses on myopia progression in Japanese children: a prospective, randomized, double-masked, crossover trial. Invest Ophthalmol Vis Sci 2008;49(7):2781-2789.
  88. Kimura S, Hasebe S, Miyata M, Hamasaki I, Ohtsuki H. Axial length measurement using partial coherence interferometry in myopic children: repeatability of the measurement and comparison with refractive components. Jpn J Ophthalmol 2007;51(2):105-110.
  89. Hamasaki I, Hasebe S, Kimura S, Miyata M, Ohtsuki H. Cycloplegic effect of 0.5% tropicamide and 0.5% phenylephrine mixed eye drops: objective assessment in Japanese schoolchildren with myopia. Jpn J Ophthalmol 2007;51(2):111-115.
  90. Miyata M, Hasebe S, Ohtsuki H. Influence of accommodative lag upon the far-gradient measurement of accommodative convergence to accommodation ratio in strabismic patients. Jpn J Ophthalmol 2006;50(5):438-442.
  91. Miyata M, Hasebe S, Ohtsuki H, Sato M. Assessment of cyclodisparity-induced slant perception with a synoptophore. Jpn J Ophthalmol 2005;49(2):137-142.